Tinzaparin Sodium Innohep Syringe from Mexico
Innohep prefilled syringes containing tinzaparin sodium, another LMWH derived from heparin sodium for treatment of acute symptomatic DVT. HTS 3004.90.92.74 applies as it contains heparin salts in therapeutic measured doses for retail sale.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit anti-factor Xa activity assay results for customs verification
• Ensure tamper-evident packaging for retail-packed syringes